Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal Transplantation

Clinical trial NCT01046955 · COMPLETED

Trial details

NCT number: NCT01046955
Sponsor: University of Miami
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

End-Stage Renal Disease Living Donors

Start date: 2005-11-01
Primary completion: 2007-04-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.